Paul W. Harms

9.3k citations
126 papers · 4.4k indexed · 1 hit paper · h-index 35

Paul W. Harms

117 papers receiving 4.4k citations

Hit Papers

Host expression of PD-L1 determines efficacy of PD-L1 pat...4492018202620202023100200300400

Peers

Paul W. Harms
Comparison fields: 5 of 126
  • Dermatology 861
  • Oncology 2.2k
  • Immunology 1.1k
  • Aerospace Engineering 727
  • Rheumatology 438
Replace Isaac Brownell with:
Isaac Brownell United States
María Teresa Fernández‐Figueras Spain
Cornelia Mauch Germany
Jennifer M. McNiff United States
Noreen M. Walsh Canada
V. del Mármol Belgium
Yutaka NARISAWA Japan
Tomomichi Ono Japan
Alvaro C. Laga United States
Claudia Pföhler Germany
Paul W. Harms relative to Isaac Brownell United States Isaac Brownell's profile →
Citations per field
00.5×3.8×
Isaac Brownell · 1×
Citations per year

Countries citing papers authored by Paul W. Harms

Since Specialization
Citations

This map shows the geographic impact of Paul W. Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Harms more than expected).

Fields of papers citing papers by Paul W. Harms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul W. Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Harms. The network helps show where Paul W. Harms may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul W. Harms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul W. Harms Line = papers co-authored together Paul W. Harms links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20251
4 20244
5 20241
6 202369
7 202213
8 20216
9 202017
10 202018
11 202022
12 2019110
13 20198
14 201912
15 201914
16 2018203
17 201729
18 201726
19 201768
20 2015234

About Paul W. Harms

Paul W. Harms is a scholar working on Dermatology, Oncology and Microbiology, having authored 126 papers that have together received 4.4k indexed citations. Recurring topics across this work include Polyomavirus and related diseases (27 papers), Full-Duplex Wireless Communications (24 papers), Cutaneous Melanoma Detection and Management (23 papers), Antenna Design and Analysis (22 papers), Cancer and Skin Lesions (18 papers), Melanoma and MAPK Pathways (12 papers), Cancer Genomics and Diagnostics (11 papers) and Dermatology and Skin Diseases (11 papers). The work is most often cited by research in Dermatology (861 citations), Oncology (2.2k citations) and Immunology (1.1k citations). Paul W. Harms has collaborated with scholars based in United States, China and India. Frequent co-authors include Douglas R. Fullen, Jóhann E. Guðjónsson, J. Michelle Kahlenberg, Rajiv M. Patel, Nallasivam Palanisamy, Lam C. Tsoi, May P. Chan, Xianying Xing, Timothy M. Johnson and Monique Verhaegen. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026